Gufic BioSciences Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹231.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.38 per cent from ₹237.05 crore. This corresponds to a year-on-year *(YoY) growth of 11.37 per cent.
Operating Profit
Operating Profit stands at ₹32.98 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.84 per cent from ₹37.84 crore. This corresponds to a year-on-year *(YoY) decline of 2.77 per cent.
PBDT
PBDT stands at ₹25.41 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 16.33 per cent from ₹30.37 crore. This corresponds to a year-on-year *(YoY) decline of 17.74 per cent.
Profit Before Tax
Profit Before Tax stands at ₹17.72 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.59 per cent from ₹22.60 crore. This corresponds to a year-on-year *(YoY) decline of 32.55 per cent.
Net Profit
Net Profit stands at ₹12.42 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 26.16 per cent from ₹16.82 crore. This represents a 35.68 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Gufic BioSciences Ltd Earnings
- YOY
- QOQ
Gufic BioSciences Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Gufic BioSciences Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Gufic BioSciences Ltd Financial Reports
Gufic BioSciences Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Gufic BioScience | 2.38% | 4.46% | 4.99% | -4.64% | -17.82% | -11.86% |
| Aarti Drugs | -0.66% | -0.28% | -0.78% | -8.16% | -30.97% | -0.51% |
| Guj. Themis Bio. | 2.27% | 10.23% | -3.21% | -24.16% | -30.12% | 3.75% |
| RPG LifeScience. | 0.96% | -0.54% | -3.92% | -18.81% | -17.82% | -13.21% |
| Orchid Pharma | 3.37% | 4.97% | 3.57% | -22.90% | -23.40% | -26.24% |
| Bliss GVS Pharma | 1.71% | 9.14% | 23.55% | 50.20% | 67.03% | 108.25% |
| Dishman Carbogen | 0.73% | 7.86% | -3.63% | -38.78% | -45.47% | -24.15% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : Jayesh P Choksi
ED / WTD / CEO / Promoter : Pranav J Choksi
Whole-time Director : Pankaj Gandhi
Independent Non Exe. Director : Anusanjiv Aurora
Independent Non Exe. Director : Kamal Kishore Seth
Independent Non Exe. Director : Akshya Kumar Mahapatra
Company Sec. & Compli. Officer : Ami Naresh Shah